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ABSTRACT
Alternative splicing (AS) is a key component of gene
expression programs that drive cellular differentia-
tion. Smooth muscle cells (SMCs) are important in
the function of a number of physiological systems;
however, investigation of SMC AS has been restricted
to a handful of events. We profiled transcriptome
changes in mouse de-differentiating SMCs and ob-
served changes in hundreds of AS events. Exons
included in differentiated cells were characterized
by particularly weak splice sites and by upstream
binding sites for Polypyrimidine Tract Binding pro-
tein (PTBP1). Consistent with this, knockdown ex-
periments showed that that PTBP1 represses many
smooth muscle specific exons. We also observed
coordinated splicing changes predicted to down-
regulate the expression of core components of U1
and U2 snRNPs, splicing regulators and other post-
transcriptional factors in differentiated cells. The lev-
els of cognate proteins were lower or similar in dif-
ferentiated compared to undifferentiated cells. How-
ever, levels of snRNAs did not follow the expression
of splicing proteins, and in the case of U1 snRNP we
saw reciprocal changes in the levels of U1 snRNA
and U1 snRNP proteins. Our results suggest that the
AS program in differentiated SMCs is orchestrated
by the combined influence of auxiliary RNA binding
proteins, such as PTBP1, along with altered activity
and stoichiometry of the core splicing machinery.
INTRODUCTION
Alternative splicing (AS) is a key contributor to remodeling
the transcriptomes of cells during development and differ-
entiation. Numerous analyses have indicated the functional
importance of AS, and highlighted the fact that AS and
transcriptional control tend to operate on different sets of
genes (1,2). Much has been learned about the cis and trans-
acting components of ‘splicing codes’ that give rise to reg-
ulated splicing programs characteristic of various adult tis-
sues. Cell-specific splicing regulatorymechanisms have been
intensely investigated in many cell types using both global
profiling and computational techniques, as well as detailed
molecular analysis of individual model splicing events (3).
Splicing programs have been well characterized in cardiac
and skeletal muscle (reviewed in (4)). By comparison, de-
spite their biomedical importance, knowledge of the regu-
lated splicing programs of smooth muscle cells (SMCs) is
more rudimentary.
SMCs are important in a number of physiological sys-
tems and organs, including the cardiovascular system. The
hallmark property of differentiated SMCs is the ability to
contract, but contractile SMCs themselves show a range of
phenotypes allowing prolonged tonic contraction in vascu-
lar smooth muscle or rapid phasic contraction in tissues
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such as bladder (5). Another distinctive characteristic, in
contrast with terminally differentiated striated muscle cells,
is that SMCs exhibit phenotypic plasticity (6). Vascular
SMCs are able to modulate their phenotype along a con-
tinuum between a contractile phenotype, characteristic of
healthy blood vessels and a more proliferative ‘synthetic’
phenotype, so-named for the enhanced synthesis and secre-
tion of extracellular matrix (ECM) components (5–9). Syn-
thetic phenotype cells are found in a number of pathologi-
cal situations such as atherosclerosis and arterial injury (8).
Phenotypic modulation can be modeled in cultured rat aor-
tic SMCs, and much is known about the changes in gene
expression levels and the underlying transcription control
networks (5,8). Likewise, the contribution of miRNA regu-
lation to SMCphenotype has beenwell documented (10). In
contrast, the contribution of AS to shaping the SMC tran-
scriptome has so far been restricted to detailed analysis of a
small number of model AS events (ASE) that are regulated
in contractile SMCs compared to synthetic cells or other tis-
sues (e.g. (11–16)), or that are regulated between contractile
SMCs from tonic and phasic smoothmuscle tissues (17–19).
While interesting mechanistic and functional insights have
been gained from these studies, it is difficult to draw gen-
eral inferences about the regulatory principles of a smooth
muscle splicing program. For example, polypyrimidine tract
binding protein (PTBP1) regulates mutually exclusive exon
selection in both the Tpm1 and Actn1 genes with smooth
muscle specificity. However, it acts in ‘opposite’ directions,
repressing the smooth muscle-specific exon of Actn1 (13–
15,20), but in Tpm1 repressing the ‘default’ exon 3 thereby
facilitating exon 2 inclusion in SMCs (21–23).
Here, we used mouse exon-junction (MJAY) arrays (24)
to gain insights into both the global contribution of ASE
in re-shaping the transcriptome of dedifferentiating SMCs,
and into the underlying regulatory mechanisms. We ob-
served numerous changes in both AS and transcript lev-
els, which affected different sets of genes. Cassette exons
(CEs) used in differentiated cells were characterized by par-
ticularly weak splice sites, and by the presence of PTBP1
binding sites in the upstream intron, associated with repres-
sion of the exons by PTBP1 in proliferative cells. Finally, we
observed a concerted set of non-productive splicing events
within the genes for snRNP proteins, other splicing fac-
tors and other post-transcriptional regulators. These splic-
ing events, which included intron retention (IR), ‘poison’
CE (i.e. CEs that introduce premature termination codons
(PTC)) inclusion and alternative polyadenylation, were all
predicted to lead to lower expression of the cognate pro-
teins in differentiated SMCs. In contrast, levels of spliceo-
somal snRNAs, particularly U1, were higher in differen-
tiated compared to proliferative cells, suggesting heteroge-
nous snRNP composition in these cells. Taken together, our
results suggest that the regulation of the AS program in
SMCs is regulated both by auxiliary RNA binding proteins
and by altered levels of core splicing factors and snRNP
composition.
MATERIALS AND METHODS
Mouse primary cells and tissue samples
Smooth muscle tissue from mouse aorta and bladder was
isolated from 10–20 week old C57BL/6 mice. Pools of five
aorta or bladder were used to harvest RNA from differenti-
ated tissue by chopping the tissue into small pieces and plac-
ing in RNAlater (Qiagen) before subsequently extracting
RNA with the Ribopure kit (Ambion). Single cell cultures
were produced from Ultra-Turrax T8 homogenized tissues
using established protocols for mouse aorta SMCs (25).
Briefly, five aortas or bladders were incubated with shaking
in 3–5ml of 1mg/ml collagenase (Sigma) and 3mg/ml elas-
tase (Worthington Biochemical Corporation) at 37 ◦C for
∼1 h. Cells were washed in phosphate buffered saline (PBS)
and larger aggregates removed with a cell strainer. Cells
were counted and either resuspended in 4% sodium dodecyl
sulphate, 125 mMTris pH6.8, 1 mMDTT, 10% glycerol for
protein lysates or plated at 4× 105 ml−1 in Dulbecco’s mod-
ified Eagle’s medium (DMEM), 10% fetal bovine serum
(FBS), 2 mM Glutamine, 1 mM Sodium Pyruvate, 1×
penicillin/streptomycin.Mediumwas changed on day 2 and
the cells split 1:2 if necessary before harvesting on day 7 or
when the cells had grown to ∼80% confluent.
Arrays and analysis
RNA from three biological replicates each of aorta medial
layer, aorta SMCs cultured for 7 days but not passaged,
bladder smooth muscle and cultured SMCs was isolated us-
ing theRibopure kit (Ambion). Total RNAwas used to pre-
pare target for hybridization to Affymetrix Mouse Exon-
Junction Array (MJAY) (26,27). The microarray data was
analyzed using ASPIRE 3.0 (Analysis of SPlicing Isoform
REciprocity, available at https://github.com/pandora2017/
ASPIRE) which analyses signal in reciprocal probe-sets to
monitor changes in ASE using the dIrank statistic, which is
a modified t-test to sort the data based on the significance
and direction of change. We routinely applied a threshold
of |dIrank|≥1 for significant events (28,29). Venn diagrams
were generated using BioVenn (30)
RT-qPCR
cDNA was prepared using 200 ng total RNA extracted
from differentiated or proliferative mouse samples, using
100 ng/l oligo dT and Superscript II (Life technologies)
following manufacturer’s instructions. Changes in isoform
expression were measured by real time polymerase chain re-
action (PCR). Primers were designed by Primer3Plus (see
Supplementary Data File 12 for primers). Exon–exon junc-
tion primers were designed specifically to detect one single
isoform. Primer performance and specificity wasmonitored
by unique melting profile and presence of a single band on
agarose gel electrophoresis. QPCR reactions were carried
out using 10 ng cDNA, 400 nM of each primer with 1×
SYBRR© Green JumpStart
TM
TaqReadyMix
TM
from Sigma.
Reactions were run in a Rotor-Gene Q instrument (QIA-
GEN), following a three-step protocol. QPCR analysis was
carried out using the Comparative Quantitation tool within
the Rotor-Gene Q Series Software 1.7. Relative expression
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values were normalized against the geometric mean of 5
genes predicted not to change by the microarray analy-
sis (Alkhb3, Hgsnat, Atp6v1e1, Bmpr2, Pol2rb). Reactions
were carried out on biological triplicates and changes were
considered significant at P < 0.05 (*), < 0.01 (**) and <
0.001 (***) by two-tailed unpaired t-test.
For conventional RT-PCR 50 ng cDNA reaction was
used as template with 400 nM primers, 3 mM MgCl2,
200 M dNTPs and JumpStartTM Taq DNA Polymerase
(SIGMA). PCR reactions were carried out at 60◦C fol-
lowing manufacturer’s instructions. PCR products were re-
solved in a QIAxcel Advanced System (QIAGEN) and
percentage of isoform inclusion measured with QIAxcel
ScreenGel software. Images shown are computer generated
from electropherograms. Values shown aremean± STDEV.
Western blot
Standard protocols for Laemmli gels and western blot-
ting were used, loading 50 g of total protein for both
single cells (D) and day 5–7 (P) cell lysates. Antibodies
for western blotting from Abcam were U1A (ab55751),
Sf3b1 (ab39578), Sf3b3 (ab96683), Srsf7 (ab138022), Tra2 
(ab66901), Rbm3 (ab134946), hnPNPL (ab6106) and Tubu-
lin (ab6160). Antibodies from Santa Cruz Biotechnology
were U1C (sc-101549), U2A’ (sc-393803), Srsf6 (sc-34198),
Rbp1 (sc-56767) and Gapdh (sc-25778). The remaining an-
tibodies were U170K/Snrnp70 Synaptic Systems (203 011),
Srsf1 Invitrogen (32-4500), PTBP1 Invitrogen (324800),
PTBP2 (kindly provided by Michele Solimena), QKI (UC
Davis/NIHNeuroMabFacility cloneN147/6), PTBP3 pro-
vided by Elisa Monzon-Casanova, Acta2 Dako (M0851)
and Myh-11 Sigma (M7786).
PAC1 cell culture
Rat PAC1 pulmonary artery SMCs (31) were grown in
DMEM supplemented with Glutamax (Invitrogen) and
10% FBS. To encourage the cells toward a more differen-
tiated state they were sub-cultured at a 1:10 dilution once
per week and for the more proliferative state they were sub-
cultured 1:20 twice per week. For siRNA transfection cells
were seeded at 105 cells per well and 24 h later transfected
with 120 pmols of siRNA and oligofectamine. A total of 90
pmols of P3 siRNAwere used against PTPB1 and 30 pmols
of N1 siRNA against PTBP2 (22) and 20 pmol Q1 for QKI
(32). Cells were transfected 24 h later using lipofectamine
2000 with the same concentration of siRNAs. Protein and
RNA were harvested 48 h after the second hit. Knock-
down efficiency was measured by running 10 g of total
cell lysate on a sodium dodecyl sulphate-polyacrylamide
gel electrophoresis gel and western blot. QKI knockdown
was also assessed by qRT-PCR. siRNA knockdown exper-
iments were done four times, and each time n = 3 at least
for each of the siRNAs. For plasmid transfections, 2 × 105
cells/well were seeded in 6-well tissue culture plates 24 h be-
fore transfection with 5 l SuperFect (QIAGEN) and 2 g
DNA with minigene:effector plasmids in a 1:4 ratio. RNA
and protein were harvested 48 h later. When plasmid trans-
fection was combined with RNAi, the plasmid was trans-
fected 5 h before the second siRNA treatment. For cyclo-
heximide treatments, 2 × 105 cells were seeded on 6-well
plates and 24 h later, 3 wells were treatedwith 100mg/ml cy-
cloheximide for 8 h and 3 wells were treated with equal vol-
ume ofDMSO.Cells were harvested in TRI reagent (Sigma)
and RNA was extracted following manufacturer’s instruc-
tions. Cycloheximide treatments were done on three inde-
pendent occasions. TG003 (T5575, SIGMA) was added to
PAC1 cells for 2 h at a concentration of 20 M. After treat-
ment cells were harvested in TRI reagent following manu-
facturer’s instructions and changes in splicingmonitored by
RT-PCR and QIAxcel. Nuclear cytoplasmic fractions from
PAC1 cells were prepared using NE-PERTM Nuclear and
Cytoplasmic Extraction Reagents (Thermo). From the re-
sulting fractionsRNAwas extracted using TRI-reagent and
RT-PCR was carried out as explained above.
Immuno-staining and RNA fluorescence insitu hybridization
(FISH)
PAC1 cells grown on coverslips were fixed for 10 min at
room temperature (RT) in 4% paraformaldehyde (PFA),
rinsed with PBS and permeabilized with 0.5% NP-40 for
2 min. Coverslips were again rinsed with PBS and incu-
bated with blocking solution (1% BSA) for 1 h at RT. Pri-
mary antibodies were diluted in blocking solution and ap-
plied to coverslips for 1 h at RT followed by three rinses in
PBS. Primary antibodies were: Rabbit anti-Snrnp70 (Mili-
pore 06–1297) diluted at 1:100, rat anti-U1C (Santa Cruz
sc-101549) at 1:100 and mouse anti-smActin Dako M0851
at 1:1000. Coverslips were incubated with secondary anti-
bodies, diluted 1:500 in blocking buffer, conjugated to Cy2
or Cy3 (Jackson Laboratory) for 1 h at RT. The coverslips
were next stained with DAPI and washed with PBS before
being mounted in ProLong Gold antifade reagent (Invitro-
gen).
For RNAfluorescence in situ hybridization (FISH) PAC1
cells grown on coverslips were fixed for 10 min at RT in 4%
PFA, dehydrated by serial incubation with 50% EtoH for
2 min, 70% EtOH for 2 min and 100% EtOH for 2 min.
Coverslips were stored at −20◦C in 100% EtOH until use.
Cells were rehydrated by incubating with 70% EtOH for 2
min and 50% EtOH for 2 min. The U1 snRNA probe (Cy3-
5′GCCAGGUAAGUAU3′) was used at 2 ng/l in 100%
formamide and heat denatured at 80◦ C for 10 min before
adding 1–5l of 2× hybridization buffer (4× SSC, 20%dex-
tran sulphate, 0.4% BSA in DEPC-water) followed by 1 l
bakers yeast tRNA (1 ng/l in formamide) and 3 l of for-
mamide. Coverslips were spotted onto the hybrization mix
and hybrizided at 37◦C overnight. Cells were washed in in
2× SSC 50% formamide at 37◦C for 15min, 2× SSC at 37◦C
for 15min, 1× SSCat 37◦ C for 15min and then equilibrated
in 4× SSC for 2 min at RT. Coverslips were stained with
DAPI andwashed twice with 1× SSCbefore beingmounted
onto slides. Immunofluorescence and RNA FISH images
were acquired using a Zeiss wide-field microscope attached
to a Zeiss Axiocam MRm camera under a 40×/1.4 NA oil
objective.
Bioinformatic analyses
Analysis of functional gene categories regulated by AS
or transcription was carried out using the statistical over-
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representation tool of PANTHER v10.0 (33) with Bonfer-
roni correction for multiple testing, which outputs both
over- and under-represented terms. We compiled reference
sets of genes (aorta, 6347; bladder, 6941) expressed above
a threshold level (ASPIRE TA ≥ 500) in either D and/or
P cells. For AS, a threshold of |dIrank| > 5 was used, and
for transcript levels a 3-fold change threshold. For analy-
sis of CE properties we compiled sets of exons upregulated
in differentiated or proliferative cells (dIrank > 1 or < -1
respectively) of both aorta and bladder, with an additional
cut-off of a predicted change in percent inclusion of >20%
(248 differentiated exons and 106 proliferative exons). As a
control unregulated set we used 2633 well annotated CEs
with predicted change of percent inclusion of <5% in both
tissues. To investigate the properties of regulated retained
introns we compiled a set of 123 introns that were more re-
tained in both aorta and bladder differentiated cells (dIrank
> 1 and dI> 20). These were compared with a control set of
annotated retained introns that were not regulated in aorta
or bladder (dIrank < 1 and dI <10), and with a set of an-
notated constitutively spliced introns (see below).
Exonic and intronic sequences were retrieved from the
mouse assembly (NCBI37/mm9). The set of constitutive in-
trons (CIs) were defined from genes with alternative events
found in the array when intronic regions satisfying the fol-
lowing criteria: do not overlap nor flankwith events, neither
with UCSC alternative events and present in all annotated
Ensembl isoforms.
Two-sidedMann–Whitney test were used to compare the
sequence properties between datasets. All statistical tests
were performed and graphics were generated with R (34).
Motif enrichments were calculated using 100 bp of the
flanking exons and the complete sequence of the CEs. For
introns we used maximum intronic flanks of 250 nt, remov-
ing 9 nt at donor side and 30 nt at the acceptor side to
avoid branch point (BP), splice site (SS) and polypyrimi-
dine tract (PPT) signals, (35), retrieving introns with a min-
imum length of 60 nt. We assess the enrichment of 5mers
and RNA compete motif matches (36) with the procedure
described in Coelho et al. (26).
Statistically over-represented motifs were selected based
on the Benjamini and Hochberg false discovery rate mul-
tiple test corrected p-value (BH-FDR < 0.05). Additional
scripts were written in PHP and Awk, and sequence logos
generated with seqlogo (37).
RESULTS
We used mouse aorta and bladder as sources of SMCs.
These two tissues showed the strongest signal in transgenic
mice carrying a splice-sensitive fluorescent reporter based
on Tpm1 SMC-specific AS (38), and also provide contrast-
ing examples of tonic and phasic smooth muscle tissues (5).
Triplicate RNA samples were purified from the intact me-
dial layer of mouse aortas and the detrusor muscle of blad-
der, and from SMCs that had been isolated from the two
tissues and cultured for 4–7 days without further passag-
ing. We subsequently refer to the tissue-derived samples as
differentiated (D) and the cultured cells as proliferative (P)
SMCs. Preliminary analysis indicated that known ASE in
the Tpm1 (39) Actn1 (15,40), Myocd (16,41) and Vcl genes
(42) were all regulated between the differentiated and prolif-
erating SMCs, as expected (Figure 2 and data not shown).
RNAwas used to prepare target for hybridization toMJAY
exon-junction arrays featuring probe-sets for all Refseq and
Ensembl annotated exons and exon-exon junctions. Data
analysis using the ASPIRE3 pipeline (29), produced sets of
predictions for changes in expression levels and in AS dur-
ing dedifferentiation of SMCs fromboth tissues (Figure 1A;
Supplementary Data Files 1 and 2).
The array analysis indicated the expected changes in ex-
pression levels of known SMC transcriptional markers dur-
ing phenotypic modulation. Reverse transcription followed
by qPCR confirmed that in aorta Myocardin (Myocd) was
downregulated by 31-fold, smoothelin (Smtn) by 7.6-fold
and smooth muscle myosin heavy chain (Myh11) by 23-fold
(Figure 1B), while non-musclemyosin heavy chain 9 (Myh9)
was upregulated by 3.7-fold. Similar changes were observed
in bladder (Figure 1B), although only the changes inMyocd
and Myh9 were significant.
A total of 4246 ASE in aorta and 5193 in bladder were
predicted to change significantly (Figure 1C and Supple-
mentary Data File 1). The distribution of regulated event
types was similar to that of all annotated events represented
on the arrays (Figure 1C), consistent with a regulated pro-
gram involving AS, alternative promoter selection and 3′
end selection. In both tissues CE, at ∼30%, were the largest
class of regulated ASE (Figure 1C). In aorta, 734 CEs were
more included in differentiated and 582 were more included
in proliferative cultured cells. Similarly in bladder 1082 CEs
were upregulated in differentiated, compared with 494 that
were more included in proliferative SMCs. Direct compar-
ison of splicing patterns between differentiated aorta and
differentiated bladder SMCs (Supplementary Data File 1)
showed about half the number of splicing differences, as
compared to the differentiated to proliferative comparisons
(2184 ASEs, including 702 CEs). Comparing ASEs that
were regulated between differentiated and proliferative cells
in both tissues, the vast majority were regulated in the same
direction. For example, of the 734 CEs upregulated in dif-
ferentiated aorta, 443 (60%) were regulated in the same di-
rection in bladder, while only 10 (1.4%) were regulated op-
positely (Figure 1D). Likewise, of the 582 proliferative aorta
exons, 237 (41%)were also upregulated in proliferative blad-
der and only 17 (2.9%) in differentiated bladder SMCs. In
contrast, comparison with published data for mouse skele-
tal muscle C2C12 cells in proliferating myoblast and ter-
minally differentiated myotube states (24) showed smaller
overlaps with no favored direction of overlap. For exam-
ple, 3.4%of aorta differentiated exonswere also upregulated
in differentiated C2C12 myotubes, while 4.0% were upreg-
ulated in proliferating myoblasts. Likewise, 2.4% of aorta
proliferative exons were also upregulated in myoblasts and
4.6% in myotubes. Thus, we have identified a large set of co-
regulated exons that are regulated specifically in SMCs of
diverse types.
The regulated ASEs include some that have previously
been analyzed experimentally including mutually exclusive
exon pairs in the Tpm1 (11,12,43) and Actn1 genes (13–
15) and CE 23 in the myosin phosphatase regulatory sub-
unit gene Pppr1r12a (17). A selection of validated exons are
shown in Figure 2 and Supplementary Figure S2, including
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Figure 1. Splice sensitive array profiling of dedifferentiating smooth muscle cells (SMCs). (A) Overall experimental design. RNA was isolated from differ-
entiated contractile SMCs of mouse aorta and bladder, and from SMCs that had been cultured for 7 days. RNAwas used to prepare target for hybridization
to splice-sensitive microarrays, followed by prediction of transcript level and splicing changes by ASPIRE. (B) qRT-PCR analysis of changes in marker
gene expression between differentiated (dark) and proliferative (light) aorta (red) and bladder (blue). (C) Distribution of regulated ASE types between
differentiated and proliferative aorta (top left) and bladder (top right) SMCs, and of all ASEs represented on the array (bottom). For this analysis events
annotated on the array as ‘promoter’ and ‘bleeding promoter’ were combined, as were ‘terminal’ and ‘bleeding terminal’. (D) Venn diagram comparing
direction of changes in CE splicing in aorta and bladder SMCs. The vast majority of CEs are coregulated in the two tissues.
8938 Nucleic Acids Research, 2016, Vol. 44, No. 18
Figure 2. Validation of cassette and mutually exclusive splicing events. Se-
lected cassette exons (CEs) with increased inclusion in differentiated (A)
or proliferative cells (B) and mutually exclusive exon events (C) were vali-
dated by RT-PCR for both aorta and bladder. Values shown are mean± sd
(n = 3) of percentage of exon inclusion. In panel C, the % inclusion of the
‘differentiated exon is indicated by the red asterisk; for Actn1 the differen-
tiated exon is smaller; for Itga7 and Tpm1 the differentiated exon amplicon
is larger. For every primer pair, a no RT control and a no template control
were run in parallel; no signal was detected in any of the reactions (not
shown). D = differentiated, P = proliferative phenotype.
exons with increased inclusion in differentiated (Figure 2A)
or proliferative (Figure 2B) SMCs, aswell asmutually exclu-
sive exon pairs (Figure 2C). CEs in Ppp1r12a, Atp2b4 and
Cacna2d1 also showed significantly higher inclusion in dif-
ferentiated bladder compared to aorta (Figure 2 and Sup-
plementary Figure S2), consistent with ASPIRE compar-
ison of aorta and bladder tissue samples (Supplementary
Data File 1), and with previous analyses of Ppp1r12a exon
23 (17).
Over-represented functional terms associated with genes
affected by AS, or transcript-level regulation were exam-
ined using PANTHER (33) (Supplementary Data File 3).
The following discussion refers to aorta, but similar ob-
servations were made for bladder. Few significantly over-
represented terms for genes affected by AS were observed.
However, when a higher threshold was applied (|dIrank|
>5), the top enriched term was ‘actin family cytoskeleton’
(P= 4.04E-09) for all regulatedASEs, and ‘non-motor actin
binding protein’ for CEs (P = 2.64E-03). In contrast, the
most significantly enriched protein function terms for genes
upregulated by > 3-fold in differentiated compared to pro-
liferative cells were receptor (P = 4.0E-07), ion channel (P
= 4.35E-7), and voltage gated ion channel (P = 1.66E-05),
which included a series of K+, Ca2+ and Na+ channels im-
portant for the excitable contractile state. Genes transcrip-
tionally upregulated in proliferative samples showed over-
representation of signaling molecule (P = 6.09E-04) and
oxygenase (P = 1.17E-03). Strikingly, ‘RNA binding pro-
teins’ were significantly under-represented among genes up-
regulated in either differentiated (P= 3.63E-08) or prolifer-
ative samples (P= 1.19E-06). Consistent with this, the array
data predicted <2-fold changes in expression levels of in-
dividual splicing regulators such as Ptbp1, Mbnl1, Mbnl2,
Srsf1, Srsf2, Srsf6 and Sfrs10/Tra2 between differentiated
and proliferative aorta SMCs. This was confirmed by qRT-
PCR for Srsf1, Srsf6, Sfsr10 (Tra2), Cugbp1, Cugbp2,Hn-
rnpL, Ptbp2, Ptbp3, Mbnl1 and Mbnl2 (Supplementary
Figure S1). Levels of Ptbp1 were observed to increase by
2.03-fold (P = 0.003) between differentiated and prolifera-
tive aorta, and a similar increase was also observed at the
protein level (see below). However, the overall modest tran-
scriptional regulation of RNA binding proteins between
differentiated and proliferative SMCs is striking in view of
the extensive program ofAS, and suggests that regulation of
this programmight be orchestrated at levels other than tran-
scription or turnover of the mRNAs for regulatory RNA
binding proteins.
Properties of smooth muscle cassette exons
We next analyzed properties of the regulated CEs, focus-
ing on events that are co-regulated in both smooth muscle
tissues and that therefore represent a core smooth muscle
AS program (Figure 3A). To this end, we collated sets of
exons that are upregulated in differentiated (443 exons, Fig-
ure 1C) or in proliferative (237 exons, Figure 1C) cells. We
applied an additional cut-off of a predicted change in per-
cent inclusion of >20% to generate sets of exons that are
robustly regulated in both tissues (248 differentiated exons
and 106 proliferative exons). As a control set we used 2633
well-annotated CEs that were not regulated in either tissue.
Differentiated CEs (DCEs) were shorter than prolifera-
tive (PCE) or control CEs (median sizes 82, 87 and 102
nt respectively, DCE versus control CE, P = 2.02 × 10−5,
Figure 3B). In contrast the size of flanking introns (Fig-
ure 3C) and their GC content (Figure 3D) did not differ
significantly between the different CE sets. As expected for
CEs (44), 5′ and 3′ splice site scores for all three groups
of CE (DCE, PCE and CE ctrl) were lower than for their
flanking constitutive exons (Figure 3E: compare ‘us Dn’
versus ‘ds Dn’, and ‘us Ac’ with ‘ds Ac’ for each set of
CEs). However, the 5′ splice sites of DCEs were signifi-
cantly weaker than those of the control CEs (P = 7.4 ×
10−5, Figure 3E: DCE ds Dn versus CE ctrl ds Dn). Like-
wise, the 3′ splice sites of DCEs were weaker than those of
control CE (P = 0.03, Figure 3E, DCE us Ac versus CE
ctrl us Ac). The 3′ splice site scores are based upon 20 nt
of intron sequence upstream of the exon (45), but branch
points and their associated polypyrimidine tracts can be lo-
cated much further upstream (46). We therefore used SVM-
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Figure 3. Properties of SMC regulated CEs and retained introns. (A) Schematic of the experimental sets of exons and introns. Top: CEs. Differentiated
exons represented in dark blue, proliferative exons in green. Bottom: regulated intron retention (IR reg), more retained in differentiated cells. (B) Length
distributions of CEs. (C) Length distributions of introns. (D) Intron GC content (%). (E) Splice site strength (Maximum Entropy). Dn = donor or 5′ splice
site, Ac––acceptor or 3′ splice site. (F) AG dinucleotide exclusion zone (AGEZ) (G) Polypyrimidine tract score associated with best predicted branch point.
Datasets analyzed in the figure: regulated CEs in proliferative (PCE) and differentiated (DCE) cells, control CEs unregulated in SMCs (CE ctrl), constitutive
introns (CIs), retained introns regulated in SMCs (IR reg), non-regulated retained introns (IR ctrl). DCE us––intron upstream of differentiated CE, DCE
ds––intron downstream of DCE, PCE us and PCE ds––introns upstream and downstream respectively of PCE, CE ctrl us and ds––introns upstream and
downstream respectively of control CEs unregulated in SMCs. Statistical tests described in ‘Materials andMethods’ section, and significant differences are
described in accompanying text. The vertical dashed line in each panel represents the median value from the CI set.
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BP finder (47) to analyze the strengths of predicted branch
points, their associated pyrimidine tracts and the size of the
AG-dinucleotide exclusion zone (AGEZ), which is indica-
tive of branch point location (46,47). DCE’s had signifi-
cantly longer AGEZ than their downstream constitutive ex-
ons (P= 0.001), or control CE (P= 10−4) (Figure 3F), and
their polypyrimidine tracts (Figure 3G) were significantly
stronger than control CEs (P = 0.0047). However, neither
the branch point scores (P = 0.09, Supplementary Figure
3), nor the distance between the predicted branch point and
3′ ss (P= 0.08, Supplementary Figure S3C) differed signifi-
cantly between differentiated and control CE. TheCEs used
in differentiated SMCs therefore share a number of proper-
ties that distinguish them from CEs in general, including a
shorter size, weaker 5′ and 3′ splice sites, but stronger pyrim-
idine tracts and larger AGEZs.
We next analyzed the differentiated and proliferative CEs
for enrichment or depletion of 3–5 mer sequence motifs.
To avoid spurious cases of enrichment based upon long re-
peat elements in a small number of introns, we carried out
the analyses by counting the cases where k-mer frequency
is above a specified threshold (see ‘Materials and Meth-
ods’ section).We applied this approach for enrichment of k-
mers (3–5 nt) as well as RNA-compete motifs correspond-
ing to >200 RNA binding proteins (36). A moderate num-
ber of enriched k-mers andRNA-competemotifs (P< 0.01)
were found in the seven transcript locations associated with
DCEs (55 motifs) and PCEs (77 motifs) (Figure 4A). How-
ever, only two motifs associated with differentiated exons,
and three with proliferative exons passed an FDR < 0.05
test (marked with asterisks in Figure 4A). The most obvi-
ous enrichment was the presence of multiple mixed C/U k-
mers corresponding to PTBP1 binding sites (e.g. UCU, P
= 5 × 10−4, FDR 0.03), as well as a PTBP1 RNA-compete
motif (P = 5.8 × 10−6, FDR 10−4) on the upstream side
of differentiated CEs, a location consistent with repression
by PTBP1 (27,48). In contrast, such motifs were not asso-
ciated with either flank of proliferative CEs. This suggests
that PTBP proteins act commonly as repressors of smooth
muscle specific exons, in non-contractile cells. No motifs
were enrichedwithin differentiatedCEs and only twowithin
proliferative CEs (Figure 4A). The only other motifs that
passed a FDR test were UUC (P = 10−4, FDR 0.0064) in
the constitutive exon upstream of proliferative exons, UAC
(P = 6.1 × 10−4, FDR 0.039) along with related motifs
(UUACC, UACC, UUAC, UACCC, UACCA) in the intron
adjacent to the upstream constitutive exon and ACUA (P=
4× 10−4, FDR 0.038) immediately downstream of prolifer-
ative exons. Other groups of similar motifs suggest possible
roles for known splicing regulators. For example, a series of
UAA containing motifs, including UUAAC (P = 0.0027),
CUAAC (P = 0.0041) and ACUAA (P = 0.019) were all
enriched on the downstream side of differentiated exons.
These motifs all resemble the binding sites for STAR pro-
teins such as Quaking, Sam68 and TSTAR (49).
To test for the potential role of PTBP proteins in regulat-
ing SMC ASEs, we knocked down PTBP1 and PTBP2 in
rat PAC1 SMCs (Figure 4B). As in other cell types, knock-
down of PTBP1 led to upregulation of PTBP2, but the el-
evated PTBP2 could be reduced by double PTBP1/PTBP2
knockdown. We analyzed the effects on 23 ASEs, including
all of those shown in Figure 2, and 5 additional DCEs in the
Srsf7, Srsf6, Sf3b3, Sfrs10 (Tra2) and Myocd genes. The
splicing patterns in the PAC1 cells resembled those of the
more proliferative mouse SMCs (compare Figures 4B and
2). Eight ASEs were found to be affected significantly (Fig-
ure 4B), five of which are DCEs upregulated by PTBP1 or
PTBP1/2 knockdown (Dock7, Atp2b4, Dst, Pkm, Actn1).
This is consistent with PTBP1 repressing these DCEs via
binding sites upstream of exons (Figure 4A). Tpm1 mutu-
ally exclusive exons 2 and 3 are an atypical PTBP1 regu-
lated event, in which PTBP1 represses the non-muscle exon
3 (21,50). Itga7 mutually exclusive exons 5 and 6 responded
in a similar manner to Tpm1, with upregulation of the PCE
upon PTBP1/2 knockdown.
We noted that the PTBP1/2 regulated Atp2b4 exon 24,
which is upregulated in differentiated SMCs, not only has
multiple PTB-binding motifs on the upstream side, but also
has 5 UAA-containing motifs (CUAA, 3 × UUAAC and
UUAA) in its downstream flank, similar to the STAR-
protein like motifs downstream of DCEs (Figure 4A). A
minigene containing Atp2b4 exon 24 and 304 nt of each
flanking intron showed increased exon inclusion in response
to Ptbp1/2 knockdown, as expected (Figure 4C). More-
over, co-transfection of expression vectors for STAR pro-
teins SLM1, TSTAR, SF1 or Sam68, but not QKI, also led
to increased exon inclusion (Figure 4D), suggesting that this
exon might be under dual control by PTBP and STAR pro-
teins.
The enriched motif ACUA (P = 4 × 10−4, FDR 0.038)
on the downstream side of PCEs also corresponds to an op-
timal QKI binding motif (49,51). QKI promotes the pro-
liferative phenotype of VSMCs, in part by promoting skip-
ping ofMyocd exon 2a (16). PCEs in the Smtn andMyo18a
genes were found to have potential QKI motifs in their
downstream intron flanks. We knocked down QKI in PAC1
cells (Supplementary Figure S4A) and observed decreased
inclusion of both the Smtn and Myo18a exons (Supple-
mentary Figure S4B), consistent with QKI activation of
these exons via downstreambinding sites. TheMyo18a exon
has two perfect QKI motifs within 65 nt of the down-
stream intron. A Myo18a minigene showed lower inclu-
sion upon knockdown of QKI in PAC1 cells, which was
partially reversed by QKI overexpression (Supplementary
Figure S4C). Moreover, single UAA to UGA mutations in
each of the two QKI sites severely reduced exon inclusion,
while mutation or deletion of both sites abolished inclusion
(SupplementaryFigure S4D). Taken together, the preceding
data show that PTBPproteins repressmany SMCexons and
also indicate a regulatory role for QKI and possibly other
STAR proteins as well.
Concerted intron retention and other non-productive splicing
in contractile cells
In contrast to the CE events, which showed similar numbers
of events upregulated in differentiated or proliferative cells,
or between aorta and bladder differentiated cells (Figures
1C, 2 and 5A), IR events were highly skewed with a large
excess of events with higher IR in differentiated cells (Fig-
ure 5A, positive dIrank values). While 216 introns showed
higher retention in differentiated aorta, only 14 showed
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Figure 4. Sequence motif enrichments reveal a role for PTB in regulating SMC CEs. (A) Motif enrichment analysis. The diagram indicates k-mer and
RNA-compete motifs enriched in the indicated regions associated with differentiated (top) or proliferative (bottom) exons. All motifs were significantly
enriched (P < 0.01). The five motifs marked with an asterisk also passed a FDR test < 0.05. Numbers adjacent to motifs indicate log2 fold enrichment.
(B) PTBP1 and PTBP2 were knockdown in rat PAC1 cells and its effects assessed in SMC CE from Figure 2. (C) Effect of PTBP1/2 knockdown in rat
PAC1 cells on Atp2b4 minigene, containing the regulated exon with 225 nt of upstream intron and 275 nt of downstream intron, cloned into an GFP
exon trapping vector. (D) Effect of overexpression of STAR family proteins on Atp2b4 minigene in rat PAC1 cells. Histograms show mean and standard
deviation of the mean of at least three samples. Statistically significance was calculated using Student’s t-test, and is shown *P < 0.05, **P < 0.01, ***P <
0.001.
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Figure 5. IR in splicing factor genes in differentiated SMCs. (A) Distribution of dIrank values of CE (left) and IR (right) events. dIrank indicates the degree
of confidence in the ASPIRE predicted change in inclusion. Positive values indicate increased inclusion in differentiated cells (D versus P comparisons,
aorta left, bladder right) or in differentiated bladder compared with differentiated aorta (middle). CEs show an even distribution of positive and negative
dIrank values in all comparisons, while IR events are skewed toward positive values in D versus P comparisons. (B–D) qRT-PCR validation of IR events.
Top, schematic representation of the event (in gray) with arrows showing primer position, and red ‘stop signs’ denoting premature termination codons
(PTCs). Bottom, plots shown are average values of relative fold change for IR or intron spliced (IS) normalized against the geometric mean of 5 genes
not changing in the microarray (see ‘Materials and Methods’ section), except for CLK1 that was normalized against its own gene expression. Dark red
represents Differentiated (D) Aorta; light red Proliferative (P) Aorta. Error bars represent standard deviation of the mean (n= 3). (B) simple IR events with
higher retention in D samples. (C) Srsf1 intron 5, showing higher retention in P samples. (D) Dual IR in Rbm3. Statistically significance was calculated
using Student’s t-test, and is shown *P < 0.05, **P < 0.01, ***P < 0.001.
higher retention in proliferative aorta. Likewise in bladder,
275 introns showed higher retention in differentiated com-
pared with only 24 for proliferative cells. In most cases IR
leads to PTC insertion and downregulation of functional
protein expression, either due to protein truncation, non-
sense mediated decay (NMD) or RNA nuclear retention
(52–57). A possible explanation for the higher levels of ob-
served IR in differentiated cells would be global downreg-
ulation of NMD, rather than regulation of splicing. Ar-
guing against this interpretation, 66% (143/216) of genes
with higher IR in differentiated aorta were associated with
decreased transcript levels (dT <1), while 86% (12/14) of
genes with decreased IR had increased transcript levels.
In contrast, CE splicing showed no association with tran-
script levels; 52% (382/735) of ‘differentiated’ CE and 49%
(284/582) of ‘proliferative’ exons were associated with de-
creased transcript levels.Moreover, many of the RNAs with
IR appear to be nuclear retained (see below), so would not
be subject to NMD.
Genes with increased IR in differentiated aorta included
a number of splicing factors (Srsf1, Sf3b1, Snrpa1, Wbp4,
Lsm7), splicing regulatory kinases (Clk1, Clk3), 3′ end pro-
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Figure 6. Other non-productive processing of splicing factors and regu-
lators. (A) ‘Poison’ CE inclusion events. (B) Combined non-productive
processing by internal polyA site selection and poison CE inclusion in
Snrnp70. (C) Internal polyA site selection. Top, schematic representation
of the regulated event (in gray) with arrows showing primer position and
red ‘stop signs’ denoting PTCs. Bottom, histograms showing average val-
ues of relative fold change for each primer pair normalized against the ge-
ometric mean of five genes not changing in the microarray, except Sf3b3
that was normalized against its own gene expression. Dark red represent
Differentiated (D) samples, light red Proliferative (P) samples. Error bars
represent standard deviation of the mean (n = 3). Exon inclusion (Inc),
exon skipping (skp), alternative 3′ end proximal (Prox), alternative 3′end
distal (Dist). For Snrnp70 gene Alternative 3′ end (Alt3′), CE inclusion
(CE Inc) or CE skipping (Prod). Statistically significance was calculated
using Student’s t-test, and is shown *P < 0.05, **P < 0.01, ***P < 0.001.
cessing factors (Cstf2), the adenosine N6 methyltransferase
(Mettl3) and the cold shock RNA binding protein Rbm3.
Validated simple IR events are shown in Figure 5B and
Supplementary Figure S5. These include intron 3 of Srsf1,
which was previously shown to lead to nuclear retention of
the RNA (54), introns 5 and 6 in Snrpa1 (encoding U2A′
protein), as well as introns in Sf3b1, Lsm7, Clk1, Clk3 and
Exod1. In Srsf1, a second IR event (Figure 5C) showed
atypical increased retention in proliferative cells. However,
this intron lies within the 3′ UTR and its splicing leads
to NMD (54) (Supplementary Figure S7), so this event
would also lead to downregulation of protein expression
in the contractile phenotype cells. Notably, the behavior of
this well documented AS-NMD event, also argues against
global downregulation of NMD in differentiated cells. In
the case of the cold shock RNA binding protein Rbm3 two
introns flanking a poison CE showed increased retention in
differentiated cells, coupled with reciprocal decrease in pro-
ductive splicing which involves skipping of the CE (Figure
5D).
Re-examination of CE events revealed additional non-
productive splicing events in splicing factor genes. Increased
inclusion of PTC-containing ‘poison’ CEs in differentiated
cells was observed for Sf3b3, Tra2 (Sfrs10), Srsf6, Srsf7
and Snrnp70 (Figure 6A, B and Supplementary Figure S6).
In addition to the known poison CE in the Snrnp70 gene
(58) encoding the U1 snRNP 70K protein, a second non-
productive event involving an internal poly(A) addition site
was also observed. Both of the non-productive splicing pat-
terns in Snrnp70 were higher in differentiated cells, while
the productive protein-coding splicing pattern increased 4-
fold in the proliferative cells (Figure 6B). Finally, we also
validated increased non-productive splicing of annotated
‘bleeding exon’ events in Hnrnpl and Cugbp2 in differenti-
ated cells (Figure 6C). These two events could either be gen-
uine alternative polyadenylation events (the Hnrnpl event
has a consensus AAUAAA 15 nt from the end of the an-
notated exon extension) or IR, since both annotated events
are followed by genomically encoded oligo A stretches.
We were unable to test whether any of the regulated non-
productively spliced RNAswere substrates for NMDor nu-
clear retained in the tissue samples used for the array anal-
ysis. However, we were able to detect some of these events
in rat PAC1 VSMCs (31). We therefore tested whether cy-
cloheximide treatment affected the ratio of spliced products
in a manner consistent with inhibition of NMD (Supple-
mentary Figure S7A) (52), and whether any of these RNA
species were preferentially retained in the nucleus (Supple-
mentary Figure S7B). We tested the effects of cyclohex-
imide upon the non-productive CE events and also the 3′
UTR IR event in Srsf1 (Supplementary Figure S7A). Poi-
son CE events in Sf3b3, Srsf7, Sfrs10 (Tra2 ) and Snrnp70
all showed apparent increased exon inclusion in response
to cycloheximide. Srsf1 intron 5 showed a decreased pro-
portion of IR (consistent with stabilization of the 3′ UTR
spliced product). These results are consistent with the non-
productive splicing patterns of these ASEs being linked
to NMD. Interestingly, we observed cycloheximide stabi-
lization of a non-productive Snrnpa1 product with exon
6 skipped in PAC1 cells (Supplementary Figure S7A). In
mouse primary samples we had observed retention of both
introns flanking exon 6, but not the exon 6 skipping event.
All but one of the detected IR events were preferentially
nuclear retained (Supplementary Figure S7B). The only ex-
ception was Srsf1 intron 5, the sole IR event that was up-
regulated in proliferative SMCs (Figure 5C) and an intron
whose splicing leads to NMD. CE events in Sf3b3 and
Snrpa1 showed no nuclear retention. However, both the
non-productive Snrnp70 splicing events showed some nu-
clear retention. The poison CE was partially retained in the
nucleus, while the annotated alternative polyA event was
highly nuclear retained, suggesting that the detected RNA
probably corresponds to IR (Supplementary Figure S7B).
Of note, inclusion of the Snrnp70 poison CE results in an
RNA that is both preferentially nuclear retained as well as
an NMD substrate.
The retained intron in CLK1 can be post-
transcriptionally spliced in response to heat or osmotic
stress or upon administration of small molecule CLK
inhibitors (57,59). Consistent with this we observed that
addition of the CLK inhibitor TG003 (20 M) (59) to
PAC1 cells led to rapid splicing of the retained CLK1 in-
tron, but none of the other IR events that we had detected
(Supplementary Figure S7C), indicating that the SMC IR
events are not all under a common mode of control with
CLK1.
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Properties of smooth muscle retained introns
To investigate the properties of the regulated retained in-
trons we compiled a set of 123 introns that were more re-
tained in both aorta and bladder differentiated cells. These
were compared with a control set of annotated retained in-
trons that were not regulated in aorta or bladder, and also
with a set of annotated constitutively spliced introns. Regu-
lated retained introns were significantly shorter than consti-
tutively spliced introns (P= 1.8× 10−8), but longer than the
unregulated control IR (P= 0.002) (Figure 3C). Consistent
with this the GC content of control IR introns was higher
than that of regulated IR introns (P = 0.0001891) or in-
trons flanking CEs (P < 5.772e-16) (Figure 3D). The splice
sites of regulated IR were slightly weaker than constitutive
splice sites, but stronger than those of the unregulated IR
events (Figure 3E), while the distance of the branch point
from the 3′ exon was smaller for both regulated and unreg-
ulated IR compared to all other datasets (Figure 3H). The
latter is probably related to the short length of these introns
(Figure 3C).
We next examined enriched sequence motifs associated
with IR events (SupplementaryFigure S8).When compared
to CI from the same genes, 24 3-mermotifs were found to be
enriched, all but one of them in the flanking exons (Supple-
mentary Figure S8A). In contrast, compared to unregulated
IR introns, enriched motifs were only found within the in-
tron; four motifs were enriched at the 5′ end of regulated IR
and three at the 3′ end (P < 0.01, FDR < 0.05). The 3-mer
GUG was enriched at the 3′ end of IR introns compared
with both unregulated IR and CIs (Supplementary Fig-
ure S8A and B). Three GUG containing k-mers (UGUG,
UUGU, UGUGC) were also enriched at the 5′ end of IR
introns. Two other significant motifs at the 3′ end of regu-
lated IRwere the RNA-compete motif for KHDRBS2 (also
known as SLM1) RAUAAAM and the related pentamer
UUAAA, whichmatches the optimal UWAA site for STAR
family members (49). These enriched motifs suggest possi-
ble mechanisms by which IR events may be regulated (see
‘Discussion’ section).
Variation of splicing factors and snRNAs
Taken together, the preceding data indicates widespread
higher levels of non-productive splicing of various RNA
splicing factors and otherRNAprocessing and binding pro-
teins in differentiated SMCs, accompanied inmany cases by
a reciprocal reduction in the levels of the productive protein-
codingmRNA isoforms (e.g. Srsf1, Srsf6, Snrnp70, Snrpa1,
Sf3b1, Sf3b3, Exod1, Rbm3, Cugbp2). Non-productive
splicing of RNA binding proteins frequently occurs in re-
sponse to high levels of the cognate protein as a result of
negative feedback loops (52,60–63)). To address whether
this is the case in the differentiated SMCs, we carried out
western blots on protein extracted from differentiated and
proliferative SMCs from mouse aorta and bladder (Figure
7A). While the levels of markers for contractile SMCs were
higher in the differentiated compared to proliferative cells
(Myh11, Acta2), the levels of the various splicing factors
and RNA binding proteins were either higher in prolifer-
ative cells (Snrnp70, Snrnpa1, Sf3b1, Srsf6, Srsf7, Rbm3)
or were not altered substantially. This suggests that in these
cases unproductive splicing is not a response to high levels
of the cognate proteins, but might be a contributing influ-
ence to their lower levels of expression in differentiated cells.
We also looked at levels of PTB proteins, which were shown
to be important in regulating many SMC ASEs (Figure 4).
Notably, levels of PTBP1 protein were higher in proliferat-
ing than differentiated aorta SMCs, consistent with a role
in repressing exons that are included in the contractile state.
The difference in PTBP1 levels between bladder differen-
tiated and proliferating cells was less marked. PTBP2 was
not detectable, except in proliferating bladder SMCs, while
PTBP3 levels changed in parallel with PTBP1.
In view of the variation in levels of core splicing fac-
tors, including snRNP proteins, we analyzed the levels of
the spliceosomal snRNAs (Figure 7B). Remarkably, qRT-
PCR analysis showed that levels of U1, U2, U4 and U5
snRNAs were all substantially higher in differentiated than
proliferative aorta SMCs. The largest difference was ob-
served for U1 snRNA, with 4.5-fold higher levels in dif-
ferentiated cells. The elevated U1 snRNA levels contrasts
with the lower levels of the U1 snRNP proteins U1 70K
(Snrnp70) and U1C in differentiated aorta samples (Figure
7A). To pursue this observation further, we used cultured
rat PAC1 SMCs which had been serially passaged under
conditions to promote more differentiated or more prolif-
erative phenotypes (Figure 7C–E). RT-qPCR showed 4–5
fold higher levels of U1 snRNA and 2.5-fold higher levels
of U4 snRNA in differentiated compared to more prolifer-
ative PAC1 cells, while levels of U2, U5 and U6 did not dif-
fer significantly (Figure 7C). Analysis of ASEs in Snrnp70,
Actn1 and Tpm1, showed changes as had been observed
in the mouse primary cells; in particular Snrnp70 showed
higher levels of non-productive splicing in the differenti-
ated cells (Figure 7D). RNA-FISH images also consistently
showed higher levels of U1 snRNA in differentiated com-
pared to proliferative PAC1 cells (Figure 7E). In contrast,
immunofluorescence microscopy showed levels of U1 70K
(Snrnp70) to be lower in differentiated compared to prolif-
erative PAC1 cells (Figure 7F), paralleling the changes in
non-productive splicing (Figure 7C). These alterations in
stoichiometry ofU1 snRNP components could have impor-
tant consequences for the various functions of U1 snRNP,
including in regulation of AS.
DISCUSSION
AS reshapes the SMC proteome
Our data demonstrate that AS plays a major role in re-
shaping the transcriptome and proteome of dedifferentiat-
ing SMCs. In particular, AS modulates the actin cytoskele-
ton, affecting genes such as Tpm1, Actn1, Cald1 and Smtn,
to convert a machinery suitable for generating contraction
at the tissue level to a form suitable for individual cell motil-
ity. For example in Actn1, the NM exon contributes to a
functional Ca2+-binding EF hand, while the SM exon lacks
ligands for Ca2+-binding so that -actinin containing struc-
tures remain stable during Ca2+-induced contraction (40).
We also observed AS changes affecting membrane voltage-
dependent Ca2+ entry channels (Cacna2d1) and Ca2+ ef-
flux pumps (Atp2b4), which are important for control of
contraction and relaxation in contractile cells, and also in
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Figure 7. Divergent levels of U1 snRNP proteins and U1 snRNA during phenotypic modulation. (A) Western blots for different splicing factors and
RNA binding proteins in mouse aorta and bladder samples, comparing differentiated (D) and proliferative (P) samples. Acta2 and Myh-11 antibodies are
markers of smooth muscle differentiation. Rpb1, Tubulin and Gapdh are loading controls. snRNA expression levels in mouse (B) and rat PAC1 cells (C)
measured by qPCR. Primers for snRNA levels were normalized against the same set of genes as in Figures 5 and 6. Error bars represent standard deviation
of the mean (n = 3). Statistically significance was calculated using Student’s t-test, and is shown *P < 0.05. (D) RT-PCR for Snrp70 (qPCR with primers
as in Figure 6) and Actn1 and Tpm1 (with primers as in Figure 2) in P and D Rat PAC1 cells. Error bars represent mean and standard deviation, (n = 3).
(E) Left panels: RNA-FISH for U1 snRNA in rat PAC1 D and P cells. Right panels show DAPI staining for nuclei. (F) Immunofluorescence in rat PAC1
cells for SNRNP70 and U1C. Sm Actin is a marker of SMC differentiation.
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genes for proteins involved in protein secretion and sorting
between different membrane bound organelles (Sec 61a2,
Sort1). A previously unreported ASE with clear predicted
functional consequences is the switch-like change from pre-
dominant skipping of Sec 61a2 exon 7 in differentiated cells
to>90% inclusion in proliferative SMCs (Figure 2). Exon 7
skipping causes frameshift and insertion of a PTC resulting
in an mRNA predicted to be degraded by NMD and/or en-
coding a protein lacking 6 of 10 transmembrane domains.
Sec 61a2 is involved in ER insertion of secreted and mem-
brane proteins, so the switch to exon 7 inclusion appears to
play an important role in activating the machinery for the
synthetic phenotype of SMCs in which large quantities of
ECM proteins are secreted (7).
AS also affects components of integrin signaling path-
ways, which are important in integrating extracellular sig-
nals to control SMC phenotype (8,9), including extracellu-
lar collagens, integrins (Itga7), tyrosine kinases (Csk, Fyn)
and actinin (Actn1).Mutually exclusive Itga7 exons 5 and 6,
encode an extracellular linker domain. This event has been
described in the context of striatedmuscle, with the X2 vari-
ant (exon 6) being used exclusively in adult skeletal mus-
cle (64). In contrast, the exon 5 (X1 variant) isoform pre-
dominates in adult aorta and bladder SMCs (Figure 2 and
Supplementary Figure S2). The X1 and X2 variants con-
fer different specificities for interaction with laminins (65).
Itga7 interacts with cartilage oligomeric matrix protein and
promotes the contractile VSMC phenotype (66), although
whether this is affected by exon 5 and 6 splicing is unclear.
Regulation of the SMC splicing program
Analysis of CEs regulated during phenotypic modulation
indicated a number of distinct features (Figures 3 and 4).
They are shorter than CEs generally, and the differentiated
exons had even weaker splice sites than control or prolifer-
ative CEs (Figure 3E), even allowing for the fact that CEs
generally have weaker splice sites than constitutive exons
(44). Differentiated exons also had larger AG dinucleotide
exclusion zones (Figure 3F) and stronger polypyrimidine
tracts within the AGEZ (Figure 3G), which could mean
that their branch point/polypyrimidine tract elements are
strong, despite the predicted weak 3′ss, which is based only
on elements within 20 nt of the 3′ss (45). Long AGEZs are
also characteristic of PTB repressed exons (27), and dif-
ferentiated exons showed significant enrichment on their
upstream intronic flank of PTBP1 binding motifs (Figure
4A), a location where PTB binding causes exon skipping
(27,48). Indeed, knockdown of PTBP1 in PAC1 cells led to
increased use of differentiated CEs in Dock7, Atp2b4, Dst,
Pkm and Actn1 (Figure 4B). This suggests that PTB com-
monly acts to repress SMC-specific exons outside of differ-
entiated cells, as has been shown for the SM exon of Actn1
(14,15). Consistent with this, western blots indicated that
PTBP1 levels were lower in aorta and bladder differentiated
cells than in cultured cells (Figure 7). Nevertheless, knock-
down of PTBP1/2 in PAC1 cells was not sufficient to switch
splicing patterns fully to the levels of exon inclusion seen
in mouse tissues (Figures 2 and 4), suggesting that other
mechanisms might be involved in countering repression by
PTBP1. Tpm1 exon 3 is an atypical case where PTBP1 acts
to repress an exon that is used in the non-differentiated cells,
allowing use of the mutually exclusive partner exon 2 (21).
Itga7 exons 5 and 6 responded to PTBP1/2 knockdown in
a similar fashion, with decreased use of the differentiated
exon 5 and increased inclusion of mutually exclusive exon 6
(Figure 4B). Consistent with the suggestion of shared regu-
latory mechanisms, Itga7 exons 5 and 6 have a very similar
splice site arrangement to Tpm1 exons 2 and 3, with mutu-
ally exclusive behavior predicted to arise from proximity of
the exon 6 branch point to exon 5. A key question for the
regulation of these two exon pairs is how PTBP1 repression
can be enhanced in differentiated cells while its activity on
the majority of exons is diminished.
Motif enrichments also suggested possible roles of QKI
or other STAR proteins (Figure 4). Indeed, QKI regulates
an overlapping set of exons with PTB in striatedmuscle cells
(24), and represses smooth muscle specific splicing of my-
ocardin exon 2a (16) (Supplementary Figure S4). QKI-like
motifs were enriched downstream of differentiated exons, a
location consistent with activation by Quaking (24). How-
ever, Quaking levels increase in dedifferentiated mouse and
human VSMCs (16), so the role of Quaking in regulating
DCEs is unclear. The related motif, ACUA, is significantly
enriched downstream of proliferating exons (Figure 4). The
decreased use of Smtn and Myo18a PCEs in response to
QKI knockdown (Supplementary Figure S4) is consistent
with QKI activation of some PCEs.
Analysis of regulated IR events (Figure 3 and Supple-
mentary Figure S8) provided some hints about how they
might be regulated. The observation that regulated IR
events have stronger splice sites than unregulated IR (Fig-
ure 3) is consistent with analysis of IR programs in dif-
ferentiating erythroblasts, and suggests the involvement of
regulatory factors in modulating IR (67). For example,
retention of 3′ terminal introns downregulates expression
of pre-synaptic proteins in non-neuronal cells and is pro-
moted by PTBP1 (68), while Sam68 promotes retention of
an Srsf1 intron (69). The SMC regulated IR introns are
enriched for GUG-containing motifs (Supplementary Fig-
ure S8). Notably, three of the seven motifs enriched down-
stream of proliferative CEs also contained a GUG mo-
tif (UCGUG, AUGUG, UGUGU, Figure 4), suggesting
that GUG-containing motifs may be important in modu-
lating the use of 5′ss between differentiated and prolifera-
tive cells, both in the context of IR and CEs. Whether they
act to downregulate splicing in differentiated cells and/or
to activate in proliferating cells is, as yet, unclear. A num-
ber of RNA binding proteins are known to bind GU-rich
motifs including CELF proteins (36,70), TDP43 (71) and
ESRP1 and 2 (72). In addition, two UA rich motifs were
enriched at the 3′ end of regulated retained introns, includ-
ing the RNA-compete motif for KHDRBS2 (also known as
Sam68 Like Mammalian protein 1). Future work will aim
to determine the pathways that lead to concerted IR and
other non-productive splicing in differentiated SMCs, and
whether these converge upon Sam68-like or GUG-binding
proteins.
Notably, the proteins that we and others have iden-
tified to be involved in regulating SMC AS, including
PTBP1 and QKI are expressed at higher levels in the non-
differentiated phenotype (Supplementary Figures S1 and 7,
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(16)). The under-representation of RNA binding proteins
(RBPs) from genes that are transcriptionally regulated be-
tween differentiated or de-differentiated cells was initially
surprising as we expect RBPs to play an important role in
orchestrating changes in AS. However, RBPs can be reg-
ulated by translation, post-translational modifications and
localization. In addition, the small number of RBPs that are
regulated at the transcript level become interesting candi-
date regulators, especially if their genes are associated with
tissue-specific superenhancers (73), indicative of proteins
with critical roles in identity of the differentiated phenotype.
The tissue samples that we used here were useful in order
to profile the transcriptomes of fully differentiated SMCs
as found in vivo. However, this system had the attendant
difficulty of experimental follow up. In the future we aim
to analyze SMC AS programs and mechanisms in an ex-
perimentally amenable system via controlled differentiation
from embryonic stem cells (74,75).
Non-productive splicing of splicing factors
Our data highlighted a concerted set of changes in non-
productive splicing within genes for splicing factors and
other post-transcriptional regulators, all of which are pre-
dicted to downregulate protein expression in the differenti-
ated contractile cells. The non-productive splicing events af-
fected SR family members (Srsf1, Srsf6, Srsf7, Sfrs10/Tra2
), components of U1 (U1 70K/Snrnp70) and U2 snRNP
(Snrpa1, Sf3b1, Sf3b3), but not of U4/5/6 snRNPs. The
events included IR, ‘poison’ CE inclusion, and alternative
3′ end formation (Figures 5 and 6). As well as simple cases
of individual IR, we also saw cases of dual IR flanking
CEs which can lead to inclusion of PTCs when included
(e.g. Rbm3) or when skipped (e.g. Snrpa1, Figure 5B and
D). The non-productive splicing patterns are all expected to
lead to downregulation of gene expression, either by NMD
of the PTC containing products (52) or by nuclear retention
of the unspliced RNAs (57,68). We were unable to address
which pathways were used in the differentiatedmouse tissue
samples used for the array analysis. However, using PAC1
cells we showed that some of the poison CE events were re-
sponsive to cycloheximide, consistent with degradation by
the translation-dependentNMDpathway, whilemost of the
IR events were preferentially nuclear retained (Supplemen-
tary Figure S7). Strikingly, the one case of IR that increased
in proliferative cells was a 3′ UTR intron in Srsf1 (Figure
5C). But in this case, productive splicing leads to a non-
productive mRNA which is a substrate for NMD (54,69)
(Supplementary Figure S6); so this event would also con-
tribute to upregulation of protein expression in the prolifer-
ative cells.
The scope of regulated IR and its role in controlling gene
expression has become increasingly apparent over the past
2 years (55–57,76–78). IR was observed to be an intrinsic
part of the granulocyte differentiation program (77), of the
heat shock response (55), and characteristic of many can-
cers (78).Moreover, a subset of apparent IR events, referred
to as detained introns, were shown to be retained in the nu-
cleus and subsequently spliced in response to specific signal-
ing pathways (57). A series of dynamically regulated non-
productive splicing events (79), including IR (67), was also
observed in erythroid cell differentiation and includedmany
of the same events affecting splicing factor genes that we
observed here. IR was shown to be accompanied by nuclear
retention of the mRNAs (67). Our observations show that
regulated non-productive splicing of splicing factor genes is
not restricted to differentiated hematopoietic cells. Indeed,
usingASPIRE to analyze published array data using for dif-
ferentiating mouse myogenic C2C12 cells (24), we observe
many of the same non-productive splicing patterns to be up-
regulated in differentiated C2C12 myotubes. In most cases
the array predicted changes were more modest in C2C12
cells than aorta or bladder SMCs, possibly reflecting the
higher degree of quiescence of differentiated cells in tissue
compared with in vitro differentiated C2C12 cells. Taken to-
gether, the available data suggest that concerted downregu-
lation of post-transcriptional regulators by a range of non-
productive splicing events might occur in many quiescent
non-proliferating cell-types. Our data shows that the non-
productive splicing ‘sub-program’ is not exclusively associ-
ated with terminally differentiating cells like erythroblasts
(67), granulocytes (77) and that it can be reversed in cells
with phenotypic plasticity such as dedifferentiating SMCs.
Many non-productive splicing events within the genes for
splicing factors and other RBPs are able to operate as neg-
ative feedback loops that act to prevent over-expression of
the cognate factor, often via NMD (52,60–63). This is not
the case in SMCs, where we observed lower levels of the
corresponding protein accompanying the non-productive
splicing in differentiated cells (Figure 7). This suggests that
in this case the non-productive splicing responds to signal-
ing that actively downregulates the steady state level of pro-
teins, possibly re-setting the level maintained by negative
feedback (73).
The core splicing machinery in transcriptome regulation
Experimental knockdown of core splicing factors has the
primary effect of altering AS splicing patterns, rather than
globally disrupting splicing (80,81). Moreover, physiologi-
cal alteration in the levels of the U2 snRNP protein Sf3b1
affects specific ASEs with clear functional consequences
(82). We observed reductions in the levels of U1 (U1 70K)
and U2 snRNP (Snrpa1, Sf3b1) proteins in aorta and blad-
der differentiated cells (Figure 7A), all of which were seen
to affect multiple ASEs upon knockdown (80). Strikingly,
the levels of the cognate snRNAs did not change in paral-
lel. This wasmost obvious forU1 snRNPwhere the levels of
U1 snRNAandU1 snRNPproteins changed in opposite di-
rections between differentiated and proliferative cells (Fig-
ure 7B–D). We cannot currently say whether the differenti-
ated cells have an excess of U1 snRNA over U1 70K protein
(encoded by Snrnp70), or whether proliferative cells have
an excess of U1 70K over U1 snRNA. The non-productive
splicing event in Snrnp70 can be promoted by a negative
feedback loop involving U1 70K and U1C proteins (58). In
the SMCs, this splicing event is not primarily driven by the
feedback loop, as the non-productive splice occurs in the
differentiated state with lower U1 70K protein and higher
U1 snRNA, which would be expected to promote the pro-
ductive splicing pattern (58). It is an intriguing possibility
that in the differentiated SMCs there is a substantial pop-
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ulation of sub-stoichiometric U1 snRNP lacking U1 70K
andU1C proteins, and that this heterogeneity inU1 snRNP
composition might play a role in regulating AS. Indeed, an
implication of the Snrnp70 feedback loop is that produc-
tive Snrnp70 splicing uses a sub-stoichiometric U1 snRNP
lacking U1 70K (58). It is an interesting possibility that the
differentiated cell CEs with particularly weak 5′ss (Figure 3)
might be preferentially activated by sub-stoichiometric U1
snRNP particles in a similar way, possibly helping to acti-
vate the exons at the same time that repression by PTBP1 is
relieved. U1 snRNP also has other roles in gene expression,
including in the suppression of promoter proximal polyA
sites, a process that involves base-pairing of U1 snRNA
with target RNAs (83,84), and may also require U1 70K
protein (85). Widespread shortening of 3′ UTRs via use of
proximal polyA sites occurs during cellular activation and
proliferation (86,87). It is therefore an interesting possibil-
ity that changes in U1 snRNA levels and snRNP composi-
tion during SMC phenotypic modulation could also affect
polyA site selection and 3′ UTR length. Our detection of
U1 snRNA was based on the sequence of the canonical U1
sequence. However, it is possible that expression of U1 vari-
ants might also play a role in differentiated SMCs (88). Fi-
nally, the imbalance between U1 snRNA and U1 70K lev-
els also has implications for snRNP assembly, in light of
the recent demonstration that U1 70K acts as a U1-specific
snRNP assembly factor, favoring assembly of U1 at the ex-
pense of the other spliceosomal snRNAs (89).
Models for regulation of AS have often posited that
the balance of positively and negatively acting regulators
can determine splicing outcomes. Our findings demonstrate
that this concept should be extended to include the ex-
pression of core splicing machinery, and possibly hetero-
geneous snRNP composition as additional influences upon
cell-specific splicing.
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